Stephen W Webster

Stephen W Webster has an estimated net worth of $6.72 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Cullinan Therapeutics, Inc., Viking Therapeutics, Inc., Spark Therapeutics, Inc., Nabriva Therapeutics plc, TCR2 THERAPEUTICS INC., NextCure, Inc., OPTIMER PHARMACEUTICALS INC, ADOLOR CORP, HEARUSA INC, and Gritstone bio, Inc..

2017 was Stephen W Webster's most active year for acquiring shares with 12 total transactions. Stephen W Webster's most active month to acquire stocks was the month of May. 2017 was Stephen W Webster's most active year for disposing of shares, totalling 12 transactions. Stephen W Webster's most active month to dispose stocks was the month of November. 2011 saw Stephen W Webster paying a total of $218,800.00 for 153,750 shares, this is the most they've acquired in one year. In 2011 Stephen W Webster cashed out on 411,250 shares for a total of $1,195,312.50, their largest year based on trade value.